NCT00975897 - Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer | Biotech Hunter

Enrollment

3,240

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

August 31, 2010

Study Completion Date

December 31, 2012

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL

bevacizumab

BIOLOGICAL

cetuximab

DRUG

fluorouracil

DRUG

irinotecan hydrochloride

DRUG

leucovorin calcium

DRUG

oxaliplatin

GENETIC

RNA analysis

GENETIC

cytogenetic analysis

GENETIC

fluorescence in situ hybridization

GENETIC

gene expression analysis

GENETIC

mutation analysis

GENETIC

protein expression analysis

OTHER

diagnostic laboratory biomarker analysis

OTHER

immunohistochemistry staining method

OTHER

questionnaire administration

PROCEDURE

cognitive assessment

Trial Locations (3)

LS9 7TF

Leeds Cancer Centre at St. James's University Hospital, Leeds

BT8 8JR

Belfast City Hospital Trust Incorporating Belvoir Park Hospital, Belfast

CF14 2TL

Velindre Cancer Center at Velindre Hospital, Cardiff